We investigated changes in the levels of MMP2 and MMP9, two key metalloproteinases, and TIMP1, a key tissue inhibitor of metalloproteinase that regulates most MMPs28,29, by following changes in the levels of FAM129A and miR-4521 in RCC cell lines. The gene discussed is MMP2; the disease is renal cell carcinoma.